Clinical Trial

Pivotal Clinical Trial to Evaluate the Efficacy and Safety After NPNP-001 Application in Patients with Knee Osteoarthritis.

Enrolling by Invitation Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated January 20, 2025 (before its estimated May 2025 completion). Its status may not reflect the trial's current state.
Summary
This study was designed to demonstrate non-inferiority and safety in pain reduction after NPNP-001 application in patients with knee osteoarthritis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-12.
Trial Details
NCT Number NCT06779071
Lead Sponsor PharmaResearch Co.,Ltd
Conditions Knee Osteoarthritis
Enrollment 260 participants
Start Date 2025-01-08
Primary Completion 2025-05 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-01-20